204 related articles for article (PubMed ID: 30190975)
1. Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.
Ganne-Carrié N; Nault JC; Ziol M; N'Kontchou G; Nahon P; Grando V; Bourcier V; Barge S; Beaugrand M; Trinchet JC; Seror O
Hepat Oncol; 2014 Oct; 1(4):395-408. PubMed ID: 30190975
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
[TBL] [Abstract][Full Text] [Related]
4. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
5. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Castellano L; Calandra M; Del Vecchio Blanco C; de Sio I
J Hepatol; 1997 Nov; 27(5):862-70. PubMed ID: 9382974
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors after Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma. Impact of Incomplete Ablation on Recurrence and Overall Survival Rates.
Sparchez Z; Mocan T; Radu P; Mocan LP; Sparchez M; Leucuta DC; Al Hajjar N
J Gastrointestin Liver Dis; 2018 Dec; 27(4):399-407. PubMed ID: 30574622
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for hepatocellular carcinoma.
Jeon HJ; Eun HS; Kwon IS; Lee BS; Lee ES; Rou WS; Sung JK; Moon HS; Kang SH; Lee HS; Kim SH; Chun K; Kim SH
Surg Endosc; 2023 Jul; 37(7):5176-5189. PubMed ID: 36947227
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of laparoscopic liver resection versus radiofrequency ablation in patients with early and small hepatocellular carcinoma: an updated meta-analysis and meta-regression of observational studies.
Shaaban Abdelgalil M; Amer BE; Yasen N; El-Samahy M; Awad AK; Elfakharany B; Saeed O; Abd-ElGawad M
World J Surg Oncol; 2024 Feb; 22(1):47. PubMed ID: 38326841
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.
Nicolini D; Svegliati-Baroni G; Candelari R; Mincarelli C; Mandolesi A; Bearzi I; Mocchegiani F; Vecchi A; Montalti R; Benedetti A; Risaliti A; Vivarelli M
World J Gastroenterol; 2013 Sep; 19(34):5622-32. PubMed ID: 24039354
[TBL] [Abstract][Full Text] [Related]
13. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.
Santambrogio R; Bruno S; Kluger MD; Costa M; Salceda J; Belli A; Laurent A; Barabino M; Opocher E; Azoulay D; Cherqui D
Dig Liver Dis; 2016 Feb; 48(2):189-96. PubMed ID: 26675381
[TBL] [Abstract][Full Text] [Related]
15. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.
Cho JY; Choi MS; Lee GS; Sohn W; Ahn J; Sinn DH; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Dec; 22(4):477-486. PubMed ID: 28081587
[TBL] [Abstract][Full Text] [Related]
18. Japanese experience in ablation therapies for hepatocellular carcinoma.
Shiina S
Hepatol Res; 2007 Sep; 37 Suppl 2():S223-9. PubMed ID: 17877487
[TBL] [Abstract][Full Text] [Related]
19. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma.
Canale M; Ulivi P; Foschi FG; Scarpi E; De Matteis S; Donati G; Ercolani G; Scartozzi M; Faloppi L; Passardi A; Tamburini E; Valgiusti M; Marisi G; Frassineti GL; Casadei Gardini A
Crit Rev Oncol Hematol; 2018 Sep; 129():44-53. PubMed ID: 30097237
[TBL] [Abstract][Full Text] [Related]
20. SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency Ablation.
Abdel-Moety A; Baddour N; Salem P; El-Tobgy H; El-Shendidi A
J Clin Exp Hepatol; 2022; 12(3):774-784. PubMed ID: 35677515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
